{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-21-046992","form_type":"8-K","ticker":"CRNX","cik":"0001658247","company_name":"Crinetics Pharmaceuticals, Inc.","filed_at":"2021-09-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.057201+00:00","generated_at":"2026-06-29T06:10:52.915754+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Crinetics appoints Jeff Knight as COO with $400k salary, 40% bonus, and 160k-share option grant","bullets":["Appointment effective August 30, 2021; Knight most recently SVP at Poseida Therapeutics.","Annual base salary of $400,000 with target annual incentive bonus of 40% of base.","Received option to purchase 160,000 shares vesting 25% on Aug 30, 2022 then monthly over 3 years.","Sign-on bonus of $40,000 in connection with commencement of employment.","Knight brings over 25 years of clinical drug development experience."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-21-046992","json":"https://secwatch.observer/filing/0001564590-21-046992.json","markdown":"https://secwatch.observer/filing/0001564590-21-046992.md","text":"https://secwatch.observer/filing/0001564590-21-046992.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658247/000156459021046992/0001564590-21-046992-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658247/000156459021046992/crnx-8k_20210830.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T06:10:52.915754+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d692845647","claim":"Jeff Knight was appointed as Chief Operating Officer at Crinetics Pharmaceuticals, Inc..","evidence_excerpt":"On September 2, 2021, Crinetics Pharmaceuticals, Inc. (the “Company” or “Crinetics”) announced the appointment of Jeff Knight as the Company’s Chief Operating Officer, which was effective as of August 30, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1658247/000156459021046992/0001564590-21-046992-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}